Gynecology in Medical Technology

FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids

... endocrinologist and Professor of Obstetrics and gynecology at Mayo Clinic in Rochester, Minnesota. ... L. Brown, MD, Professor of Obstetrics and gynecology and chair of the Department of Obstetrics and gynecology at Duke University Medical Center. "An ...

Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta

... younger women," said Dr. Dale Leitman, from the Department of Obstetrics, gynecology and Reproductive Sciences at the University of California, San Francisco. ... at The Center for Reproductive Science in the Department of Obstetrics, gynecology and Reproductive Sciences at the University of California, San Francisco ...

Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs

... effects," said Dr. Dale Leitman, from the Department of Obstetrics, gynecology and Reproductive Sciences at the University of California, San Francisco. ... at The Center for Reproductive Sciences in the Department of Obstetrics, gynecology and Reproductive Sciences at the University of California, San Francisco ...

First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices

... devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. Ethicon Endo-Surgery is actively leading the development of NOTES through research to determine the most appropriate ...

Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Company's Toolbox

... devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. Ethicon Endo-Surgery, Inc., is actively leading the development of NOTES through research to determine the most ...

FDA Advisory Panel Recommends Approval of the SEDASYS(R) System

... devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. More information can be found at www.ethiconendo.com . (C)2009 Ethicon Endo-Surgery SEDASYS(R) is a trademark ...

RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days

... distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of branded pharmaceuticals focused on Urology, gynecology and Nephrology (Medical). In the U.S., the Watson portfolio includes RAPAFLO(TM), GELNIQUE(TM), TRELSTAR(R) LA; TRELSTAR(R) Depot; ...

Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)

... distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of branded pharmaceuticals focused on Urology, gynecology and Nephrology (Medical). In the U.S., the Watson Brand portfolio includes RAPAFLO(TM), GELNIQUE, TRELSTAR(R) LA, TRELSTAR(R) Depot, ...

Nationwide Survey Shows Infertility Patients Prefer ENDOMETRIN(R) Compared With Other Progesterone Supplements

... in the research, development and commercialization of compounds in general and pediatric endocrinology, urology, gastroenterology, obstetrics/ gynecology and infertility. For more information, call 888-337-7464 or visit http://www.ferringusa.com or http://www.ferringfertility.com . Contact Andrea ...

National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births

... of babies," said Alan Peaceman, MD, chair of the Division of Maternal Fetal Medicine at Northwestern Memorial Hospital, professor of Obstetrics and gynecology at the Northwestern University Feinberg School of Medicine, and an investigator in the study. "After 10 years of studying the effects of magnesium ...

New Research on Pre-Eclampsia in Mice May Have Important Implications for Humans

... Xia, M.D., Ph.D., and Rodney E. Kellems, Ph.D., Department of Biochemistry and Molecular Biology; and Susan M. Ramin, M.D., Department of Obstetrics, gynecology and Reproductive Science, all at the University of Texas-Houston Medical School, and colleagues report today in the journal Nature Medicine that they ...

Bionovo's Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation

... selective regulation." The study was conducted by investigators at The Center for Reproductive Sciences in the Department of Obstetrics, gynecology and Reproductive Sciences at the University of California, San Francisco in collaboration with scientists at Bionovo. "Although estrogens are very ...

QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy

... of the most common and debilitating symptoms of vulvovaginal atrophy," said James A. Simon, M.D., CCD, FACOG, Clinical Professor of Obstetrics and gynecology at the George Washington University. Ophena(TM) is a novel selective estrogen receptor modulator (SERM) that is being studied as a non-estrogen ...

Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol

... devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. More information can be found at http://www.ethiconendo.com . About DDW DDW is the largest international gathering of ...

PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery

... (ACOG) 56th Annual Clinical Meeting in New Orleans by lead investigator Dr. Paul Blumenthal, M.P.H., professor in the Department of Obstetrics and gynecology at Stanford University School of Medicine. "The findings of this comparative preclinical study of tissue cutting and healing are encouraging ...

Divigel(R) (estradiol gel) 0.1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated with Menopause

... for the management of hot flashes, the most common physical sign of menopause," said Dr. Ricki Pollycove, fellow, American College of Obstetrics and gynecology and clinical faculty member, University of California, San Francisco. "However, because of misconceptions that still exist today due to the influx ...

Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being

... to the pill and 3 percent to the skin patch. About the study The three-month study was carried out at outpatient clinics of the departments of gynecology and family planning centers of public and private institutions throughout Spain in 2006. In total 458 physicians participated. Women aged 18 to 49 ...

Women Invited to Join New Health Registry to Advance Research

... play a significant role in health beyond the reproductive system," added Woodruff, who also is the Thomas J. Watkins Professor of Obstetrics and gynecology at the Feinberg School. "Scientists now realize that sex differences influence virtually every body system." Women who join the registry will be ...

Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms

... symptoms (hot flashes). In both qualitative and quantitative studies, 124 physicians board certified in internal medicine or obstetrics and gynecology specializing in the treatment of menopause reported MF101, if approved, would be their drug of choice for the treatment of hot flashes. In addition, ...

New Data Show Unacceptably Low Adult Immunization Rates and That Adults Unaware of Infectious Disease Threat

... PHN pain can last for years after the initial shingles outbreak and is often resistant to treatment. Stanley A. Gall, MD, Professor of Obstetrics, gynecology and Women's Health and the American College of Obstetricians and Gynecologists (ACOG) Liaison Member to the Advisory Committee on Immunization ...

New Data Presented on the Renessa(R) Treatment for Female Stress Urinary Incontinence

... treatment," she continued. The trial results will also be presented during a poster session at the upcoming Global Congress of Minimally Invasive gynecology in Washington, DC. Highlights of the six month results include: -- 74% of women showed an improvement in their symptoms with 63% of women ...

Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia

... partnerships, Organon seeks to leverage its position as a leading biopharmaceutical company in each of its core therapeutic fields: fertility, gynecology and selected areas of anesthesia. It has extensive expertise in neuroscience and a rich and focused R&D program. Research areas also include ...

Bonnie Blair to Break the Ice About Stress Urinary Incontinence in Milwaukee

... needed and creates a "tension-free" treatment solution that reduces the risk of over-correcting. A study published in the Journal of Obstetrics and gynecology (Dec 2004) shows that 7 years after treatment, 81% of those affected were cured and 16% were improved. To date, over 1 million women worldwide have ...

Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World

... in the research, development and commercialization of compounds in general and pediatric endocrinology, urology, gastroenterology, obstetrics/ gynecology and infertility. For more information, call 888-337-7464 or visit http://www.ferringusa.com or http://www.ferringfertility.com . *Crinone ...

Researchers Discover Gene For Rare Skin Disorder

... The study was lead jointly by Xiaoling Wang, Department of Obstetrics and gynecology at Baylor College of Medicine, and V. Reid Sutton, Department of Molecular ... professor at Baylor College of Medicines Departments of Obstetrics and gynecology and of Molecular and Human Genetics and the senior author of the paper. ...

Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Children's Hospital and Stanford

... the care of their newborn. Lyell, assistant professor of obstetrics and gynecology at the medical school, and Yasser El-Sayed, MD, associate professor of obstetrics and gynecology at the medical school, are the lead and senior authors respectively of the ...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

... who may benefit from HspE7." Dr. Einstein is Director of Clinical Research for the Division of Gynecologic Oncology, Department of Obstetrics and gynecology & Women's Health at the Montefiore Medical Center at Albert Einstein College of Medicine. Gregory M. McKee, President and Chief Executive ...

Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100 Percent Protection Against Precancerous Lesions Caused By Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than Five Years

... us who are working to prevent cervical cancer, and for women around the world," said Dr. Stanley Gall, lead investigator and Professor of Obstetrics, gynecology and Women's Health at the University of Louisville, Kentucky. "Demonstrating 100 percent efficacy and sustained immune response for more than five ...

New Position Statement from The North American Menopause Society Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in Postmenopausal Women

... time regardless of whether estrogen therapy is used," said Gloria A. Bachmann, MD, Associate Dean for Women's Health, Professor of Obstetrics and gynecology and Professor of Medicine, UMDNJ, Robert Wood Johnson Medical School, New Brunswick, NJ, and Chair of the Editorial Board. "In contrast, vaginal ...

New England Journal of Medicine Publishes New Data on Gardasil, Merck's Cervical Cancer Vaccine

... to the relevant HPV types targeted by the vaccine," said Kevin Ault, M.D., associate professor, Division of Gynecologic Oncology, Department of gynecology and Obstetrics, Emory University School of Medicine, Atlanta. "Widespread immunization of 11- to 26-year-old girls and women with GARDASIL, along ...

Organon's Asenapine Effective in a Phase III Study for the Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA Meeting

... Organon seeks to leverage its position as a leading biopharmaceutical company in each of its core therapeutic fields: fertility, gynecology and selected areas of anesthesia. It has extensive expertise in neuroscience and a rich and focused R&D program. Research areas also include ...

Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial Compared to Neostigmine

... partnerships, Organon seeks to leverage its position as a leading biopharmaceutical company in each of its core therapeutic fields: fertility, gynecology and selected areas of anesthesia. It has extensive expertise in neuroscience and a rich and focused R&D program. Research areas also include ...

Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine

... Organon seeks to leverage its position as a leading biopharmaceutical company in each of its core therapeutic fields: fertility, gynecology and selected areas of anesthesia. It has extensive expertise in neuroscience and a rich and focused R&D program. Research areas also include ...

Two Phase III clinical trials on corifollitropin alfa (Org 36286) reach randomization target

... partnerships, Organon seeks to leverage its position as a leading biopharmaceutical company in each of its core therapeutic fields: fertility, gynecology and selected areas of anesthesia. It has extensive expertise in neuroscience and a rich and focused R&D program. Research areas also include ...

Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types

... of the patients seen by physicians every day in their practice," said lead investigator Professor Jorma Paavonen, Department of Obstetrics and gynecology at Helsinki University Central Hospital, Finland. "This provides a strong indication that this vaccine can protect women from the infections that may ...